The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.
Power firm Aggreko remains overbought after a strong performance by the shares in recent sessions, while InterContinental Hotels is back on the list after reports it rejected a £6 billion bid from a rival. No detail has been provided on the identity of the suitor, but some have suggested an American firm may be in the frame as it seeks to achieve tax re-domiciling, an aim of Pfizer’s in its (currently) thwarted bid to acquire AstraZeneca.